Literature DB >> 21785545

Immune globulin intravenous (human), 5% liquid gammaplex: for replacement therapy of primary humoral immunodeficiency.

.   

Abstract

Entities:  

Year:  2011        PMID： 21785545      PMCID： PMC3138361     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  20 in total

Review 1.  Pharmacy considerations for the use of IGIV therapy.

Authors:  Sachin Shah
Journal:  Am J Health Syst Pharm       Date:  2005-08-15       Impact factor: 2.637

Review 2.  Adverse events associated with intravenous immunoglobulin therapy.

Authors:  David J Hamrock
Journal:  Int Immunopharmacol       Date:  2005-12-13       Impact factor: 4.932

Review 3.  Primary immunodeficiency diseases. Report of a WHO Scientific Group.

Authors: 
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

4.  Requirements for safety and quality of intravenous immunoglobulin G preparations.

Authors:  G H Rütter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.

Authors:  H W Eijkhout; J W van Der Meer; C G Kallenberg; R S Weening; J T van Dissel; L A Sanders; P F Strengers; H Nienhuis; P T Schellekens
Journal:  Ann Intern Med       Date:  2001-08-07       Impact factor: 25.391

6.  Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

Authors:  Ann Gardulf; Uwe Nicolay; Dipl Math; Oscar Asensio; Ewa Bernatowska; Andreas Böck; Beatriz T Costa-Carvalho; Carl Granert; Stefan Haag; Dolores Hernández; Peter Kiessling; Jan Kus; Nuria Matamoros; Tim Niehues; Sigune Schmidt; Ilka Schulze; Michael Borte
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

Review 7.  Primary immunodeficiencies.

Authors:  Megan A Cooper; Thomas L Pommering; Katalin Korányi
Journal:  Am Fam Physician       Date:  2003-11-15       Impact factor: 3.292

8.  Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS/WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 9.  Antibody deficiency.

Authors:  R Herriot; W A C Sewell
Journal:  J Clin Pathol       Date:  2008-09       Impact factor: 3.411

Review 10.  Diagnosis of immunodeficiency: clinical clues and diagnostic tests.

Authors:  Mary E Paul
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.